ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Overweight

Diabetes trials near Birmingham, AL, USA:

Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)

Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...

Active, not recruiting
Diabetes Mellitus, Type 2
Behavioral: Diabetes Education Class
Behavioral: Remote Patient Monitoring (RPM)
The University of Alabama at Birmingham
The University of Alabama at Birmingham

Birmingham, Alabama, United States

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Birmingham, Alabama, United States and 44 other locations

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Birmingham, Alabama, United States and 56 other locations

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY)

placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...

Enrolling
Diabetes, Type II
Obesity
Drug: AZD6234
Drug: Placebo to match

Phase 2

AstraZeneca
AstraZeneca

Birmingham, Alabama, United States and 17 other locations

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Birmingham, Alabama, United States and 89 other locations

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Screening Program): Home Kit
Other: (IRIS-CKD Screening Program): Standard Lab Order
Duke University
Duke University

Birmingham, Alabama, United States and 3 other locations

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Management Program): Education
Other: (IRIS-CKD Management Program): GDMT
Duke University
Duke University

Birmingham, Alabama, United States and 2 other locations

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Vestavia Hills, Alabama, United States and 96 other locations

Status recently updated

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide (RENEW 2)

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Not yet enrolling
Enrolling
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Birmingham, Alabama, United States and 66 other locations

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes...

Enrolling
Type 2 Diabetes
Overweight
Other: Placebo
Drug: Petrelintide

Phase 2

Zealand Pharma
Zealand Pharma

Cullman, Alabama, United States and 48 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2025 Veeva Systems